Tetroxoprim

Tetroxoprim (INN) is a derivative of trimethoprim. It was first described in 1979.^[1][2][3]

Tetroxoprim

Clinical data
ATC code	J01EE06 (WHO) (with sulfadiazine)
Identifiers
IUPAC name 5-[3,5-Dimethoxy-4-(2-methoxyethoxy)benzyl]pyrimidine-2,4-diamine
CAS Number	53808-87-0^Y
PubChem CID	65450
ChemSpider	58910^N
UNII	5R6712AY0K
KEGG	D06097^Y
ChEMBL	ChEMBL32039^N
CompTox Dashboard (EPA)	DTXSID80202085
ECHA InfoCard	100.053.427
Chemical and physical data
Formula	C16H22N4O4
Molar mass	334.376 g·mol^−1
3D model (JSmol)	Interactive image
SMILES COCCOC1=C(C=C(C=C1OC)CC2=CN=C(N=C2N)N)OC
InChI InChI=1S/C16H22N4O4/c1-21-4-5-24-14-12(22-2)7-10(8-13(14)23-3)6-11-9-19-16(18)20-15(11)17/h7-9H,4-6H2,1-3H3,(H4,17,18,19,20)^N Key:WSWJIZXMAUYHOE-UHFFFAOYSA-N^N
^NY (what is this?)  (verify)

Its chemical formula is C=16 | H=22 | N=4 | O=4. ^[2][3]

References

1. Aschhoff HS, Vergin H (November 1979). "Tetroxoprim—a new inhibitor of bacterial dihydrofolate reductase". J Antimicrob Chemother. 5 (B): 19–25. doi:10.1093/jac/5.supplement_b.19. PMID 43863.
2. "Tetroxoprim". pubchem.ncbi.nlm.nih.gov.
3. "Tetroxoprim - an overview | ScienceDirect Topics". www.sciencedirect.com.